Legislation & Regulation

The Academy of Managed Care Pharmacy (AMCP) supports the passage of Senate Bill 1024. This bill would remove the December 31, 2016 sunset date currently in force which allows health care payment or benefit provider’s access to the state electronic system for monitoring schedules 2-5 controlled substances.

AMCP CEO Blog: Information is the life blood of managed care pharmacy. Of the “competent and reliable scientific” variety, that is.

On April 4, 2016, CMS released its 2017 Final Call Letter. CMS acknowledged AMCP in the 2017 Final Call Letter and credits the important work that AMCP’s Medication Therapy Management Advisory Group is doing to develop a framework to define drug therapy problems. Additionally, CMS altered its timeline for removing the high-risk medication (HRM) measure from the Star Ratings from 2017 to 2018.

Press Release: The Academy of Managed Care Pharmacy (AMCP) urges the full Senate to pass the “Comprehensive Addiction and Recovery Act of 2016” (S. 524) with a provision that tackles the issue of opioid abuse and diversion among Medicare Part D beneficiaries.

AMCP summary of the CMS 2017 Draft Call Letter.

Press Release: The Academy of Managed Care Pharmacy has prepared a detailed summary of the 2017 Draft Call Letter released Feb. 19 by the Centers for Medicare and Medicaid Services (CMS).

AMCP Summary: Advance Notice of Methodological Changes for Calendar Year (CY) 2017 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter

CMS CY 2016 Formulary Information

CMS December 2015 Memorandum on Part D Transition Monitoring Program

Centers for Medicare and Medicaid Services (CMS) is issuing this memorandum to provide clarifying guidance to Medicare Part D plan sponsors concerning the Part D program’s any willing pharmacy (AWP) requirement.

CY 2016 Medication Therapy Management Program Guidance and Submission Instructions

CMS Call Letter.